Published in Br J Urol on December 01, 1997
Comparison of new immunohistochemical assay for oestrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassay. J Clin Pathol (1994) 1.62
Non-invasive in vivo imaging in small animal research. Cell Oncol (2006) 1.55
Characterization and assessment of a novel poly(ethylene oxide)/polyurethane composite hydrogel (Aquavene) as a ureteral stent biomaterial. J Biomed Mater Res (1998) 1.49
Uterine carcinosarcoma in association with tamoxifen therapy. Br J Obstet Gynaecol (1997) 1.48
Response to specific anti-oestrogen (ICI182780) in tamoxifen-resistant breast cancer. Lancet (1995) 1.47
Efficacy and safety peri-prostatic local anaesthetic injection in trans-rectal biopsy of the prostrate: a prospective randomised study. Surgeon (2004) 1.44
Reduced apoptosis and proliferation and increased Bcl-2 in residual breast cancer following preoperative chemotherapy. Breast Cancer Res Treat (1998) 1.39
How to develop and use a Bayesian Belief Network. J Clin Pathol (1996) 1.29
An automated machine vision system for the histological grading of cervical intraepithelial neoplasia (CIN). J Pathol (2000) 1.28
Interobserver variation in the reporting of cervical colposcopic biopsy specimens: comparison of grading systems. J Clin Pathol (1996) 1.21
Improved diagnostic decision-making in pathology: do inference networks hold the key? J Pathol (1995) 1.20
Embryonal carcinoma of testis simulating seminoma. J Clin Pathol (1987) 1.20
Comparison of p53 and DNA content abnormalities in adenocarcinoma of the oesophagus and gastric cardia. Br J Cancer (1998) 1.14
Evidence of prostate cancer screening in a UK region. BJU Int (2004) 1.13
Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer. Br J Cancer (2000) 1.13
In vivo measurement of aromatase inhibition by letrozole (CGS 20267) in postmenopausal patients with breast cancer. Clin Cancer Res (1995) 1.12
Mantle cell lymphoma presenting as a breast mass. J Clin Pathol (2001) 1.12
Inter- and intra-observer variation in the histopathological reporting of cervical squamous intraepithelial lesions using a modified Bethesda grading system. Br J Obstet Gynaecol (1998) 1.11
Expression of epidermal growth factor receptor and c-erbB2 during the development of tamoxifen resistance in human breast cancer. Clin Cancer Res (1997) 1.07
Thirty-year review of intrascrotal rhabdomyosarcoma. Br J Urol (1991) 1.06
Characterization of biofilm and encrustation on ureteric stents in vivo. Br J Urol (1994) 1.05
Prostatic intraepithelial neoplasia. Development of a Bayesian belief network for diagnosis and grading. Anal Quant Cytol Histol (1994) 1.02
Breast cancer in women under 40 years of age: a series of 57 cases from Northern Ireland. Breast (2010) 1.01
Prostatic intraepithelial neoplasia (PIN). Performance of Bayesian belief network for diagnosis and grading. J Pathol (1995) 1.00
Chromatin texture signatures in nuclei from prostate lesions. Anal Quant Cytol Histol (1998) 0.99
Preclinical antitumor activity and pharmacodynamic studies with the farnesyl protein transferase inhibitor R115777 in human breast cancer. Clin Cancer Res (2001) 0.99
Computerized scene segmentation for the discrimination of architectural features in ductal proliferative lesions of the breast. J Pathol (1997) 0.99
T- and L-type Ca2+ currents in freshly dispersed smooth muscle cells from the human proximal urethra. J Physiol (2003) 0.98
BCAR1/p130Cas expression in untreated and acquired tamoxifen-resistant human breast carcinomas. Int J Cancer (2000) 0.97
Consensus statement. Workshop on therapeutic resistance in breast cancer: impact of growth factor signalling pathways and implications for future treatment. Endocr Relat Cancer (2005) 0.97
Induction of apoptosis by tamoxifen and ICI 182780 in primary breast cancer. Int J Cancer (1997) 0.97
Uterine serous carcinoma and endometrial intraepithelial carcinoma arising in endometrial polyps: report of 5 cases, including 2 associated with tamoxifen therapy. Hum Pathol (2003) 0.95
Nuclear chromatin texture in prostatic lesions. II. PIN and malignancy associated changes. Anal Quant Cytol Histol (1998) 0.94
Comparative assessment of ureteral stent biomaterial encrustation. Biomaterials (1996) 0.93
Light microscopic and three-dimensional morphology of the human muscular sarcocyst. Parasitol Res (1994) 0.92
Computerized diagnostic decision support system for the classification of preinvasive cervical squamous lesions. Hum Pathol (2003) 0.92
Inhibition of amyloid fiber assembly by both BiP and its target peptide. Immunity (2000) 0.92
Automated reasoning system in histopathologic diagnosis and prognosis of prostate cancer and its precursors. Eur Urol (1996) 0.91
WHO reclassification of breast lymphomas. J Clin Pathol (2004) 0.90
Monoclonal antibodies Ki-67 and MIB1 in the distinction of tuboendometrial metaplasia from endocervical adenocarcinoma and adenocarcinoma in situ in formalin-fixed material. Int J Gynecol Pathol (1995) 0.90
Tissue architecture analysis in prostate cancer and its precursors: An innovative approach to computerized histometry. Eur Urol (1999) 0.90
Myeloid sarcoma of the small bowel associated with a CBFbeta/MYH11 fusion and inv(16)(p13q22): a case report. J Clin Pathol (2009) 0.89
Time-related effects of estrogen withdrawal on proliferation- and cell death-related events in MCF-7 xenografts. Int J Cancer (1999) 0.89
Morphometrical analysis in ulcerative colitis with dysplasia and carcinoma. Histopathology (1987) 0.88
The haematuria clinic--referral patterns in Northern Ireland. Ulster Med J (1998) 0.87
Laser lithotripsy for ureteric calculi: results in 250 patients. Ulster Med J (1995) 0.87
Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer. Cancer Res (1995) 0.87
Superficial gastritis and Campylobacter pylori in dyspeptic patients--a quantitative study using computer-linked image analysis. J Pathol (1989) 0.87
Mechanical performance of polyurethane ureteral stents in vitro and ex vivo. Biomaterials (1997) 0.86
Assessment of oesophagitis by histology and morphometry. Histopathology (1989) 0.86
The effects of l-arginine on crypt cell hyperproliferation in colorectal cancer. J Surg Res (1999) 0.86
Development of a model for assessment of biomaterial encrustation in the upper urinary tract. Biomaterials (1996) 0.86
Daily, monthly and seasonal variation in PSA levels and the association with weather parameters. Prostate Cancer Prostatic Dis (2010) 0.86
Cell proliferation studies in primary synovial chondromatosis. J Pathol (1998) 0.85
Re: Crew JP, Jephcott CR, Reynard JM. Radiation-induced haemorrhagic cystitis. Eur Urol 2001;40(2):111-23. Eur Urol (2003) 0.85
High metallothionein expression is associated with features predictive of aggressive behaviour in endometrial carcinoma. Histopathology (1999) 0.85
Gene therapy with autologous, interleukin 2-secreting tumor cells in patients with malignant melanoma. Hum Gene Ther (1999) 0.85
Apoptosis and cell-cycle regulatory proteins in colorectal carcinoma: relationship to tumour stage and patient survival. J Pathol (2001) 0.84
Multimodality therapy in inflammatory breast cancer: is there a place for surgery? Ann Oncol (2000) 0.84
Morphometric analysis of colorectal cancer. Dis Colon Rectum (1993) 0.84
Data representation and reduction for chromatin texture in nuclei from premalignant prostatic, esophageal, and colonic lesions. Cytometry (2000) 0.84
Advances in cell kinetics. BMJ (1991) 0.84
Detection of wild type and exon 5-deleted splice variant oestrogen receptor (ER) mRNA in ER-positive and -negative breast cancer cell lines by reverse transcription/polymerase chain reaction. J Mol Endocrinol (1994) 0.83
Effect of folate supplementation on mucosal cell proliferation in high risk patients for colon cancer. Gut (2002) 0.83
Induction of apoptosis by mitomycin-C in an ex vivo model of bladder cancer. BJU Int (2000) 0.83
Transcontinental communication and quantitative digital histopathology via the Internet; with special reference to prostate neoplasia. J Clin Pathol (2002) 0.83
Haemodialyser reuse: impact on function and biocompatibility. Int J Artif Organs (1983) 0.83
Clinical studies of apoptosis and proliferation in breast cancer. Endocr Relat Cancer (1999) 0.83
p53 mutation, allele loss on chromosome 17p, and DNA content in ovarian carcinoma. J Pathol (1996) 0.82
Evaluation of prostatic intraepithelial neoplasia after treatment with a 5-alpha-reductase inhibitor (finasteride). A methodologic approach. Anal Quant Cytol Histol (1996) 0.82
The role of morphometry in predicting prognosis in pancreatic islet cell tumors. Cancer (1989) 0.82
The use of thioglycolic acd in hair-bearing skin inlay urethroplasty. Br J Urol (1980) 0.82
Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancer. Clin Cancer Res (1999) 0.82
Ileal conduit-enteric fistula. Br J Urol (1993) 0.81
Lipid peroxidation assessment of free radical production following release of obstructive uropathy. J Urol (1996) 0.81
Architectural morphometry in ulcerative colitis with dysplasia. Histopathology (1988) 0.81
Continuous infusional combination chemotherapy in inflammatory breast cancer: a phase II study. Breast (2000) 0.81
Bladder hamartoma. Br J Urol (1993) 0.81
Machine vision-based histometry of premalignant and malignant prostatic lesions. Pathol Res Pract (1995) 0.81
Nuclear chromatin texture in prostatic lesions. I. PIN and adenocarcinoma. Anal Quant Cytol Histol (1998) 0.81
Subtle morphological and molecular changes in normal-looking epithelium in prostates with prostatic intraepithelial neoplasia or cancer. Eur Urol (1999) 0.81
Oestrogen receptor mutants and variants in breast cancer. Eur J Cancer (1997) 0.80
Screening for ESR mutations in breast and ovarian cancer patients. Hum Mutat (1997) 0.80
Phenotypic changes in mitochondrial membrane potential (Delta psi(m)) during valinomycin-induced depolarisation and apoptosis. Cell Oncol (2005) 0.80
Combining platinum, paclitaxel and anthracycline in patients with advanced gynaecological malignancy. Eur J Cancer (2000) 0.80
Downregulation of Bcl-2 sensitises interferon-resistant renal cancer cells to Fas. Br J Cancer (2004) 0.80
Bcl-2/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro apoptosis and clinical resistance. Br J Cancer (1998) 0.80
EGFR/HER2 inhibitor AEE788 increases ER-mediated transcription in HER2/ER-positive breast cancer cells but functions synergistically with endocrine therapy. Br J Cancer (2010) 0.80